2023 CDC data suggest the STI epidemic may be slowing
Description
The number of sexually transmitted infections (STIs) remains high in the United States, however the latest data from CDC show signs the epidemic could be slowing
1 - 10 of 109 results found
2023 Update: U.S. Surveillance of Sexually Transmitted Infections
Description
Although rates of bacterial STIs have largely stabilized, case counts remain high.
AI and the FDA
Description
A recent Special Communication published in JAMA points out that the FDA has already approved nearly 1000 devices using AI. Author Robert M. Califf, MD, commissioner of the US Food and Drug Administration, joins JAMA+ AI Editor in Chief Roy H. Perlis
Anticoagulation During Hospitalization for COVID-19
Description
A meta-analysis reaffirms generally better outcomes with therapeutic than with prophylactic anticoagulation — with some exceptions.
Are Novel PICC Materials Better Than Conventional Polyurethane PICCs?
Description
In this randomized trial, peripherally inserted central catheters made with novel materials did not have lower failure rates than conventional polyurethane PICCs.
Blood Pressure Treatment Not Just for Those with High BP, Meta-Analysis Suggests
Description
Blood pressure (BP)–lowering treatment is associated with lower risk for cardiovascular (CV) events across a wide range of BP levels and in patients with...
BMI Above 23 Linked to Worse COVID-19 Outcomes
Description
Higher body-mass index is associated with increased risk for severe COVID-19–related outcomes, even at a BMI considered a healthy weight, according to...
California confirms first clade I mpox case
Description
CDC to receive samples for additional viral characterization.
Can Tracking Inflammatory Biomarkers Shorten Antibiotic Duration in Patients with Sepsis?
Description
Measuring procalcitonin shortened antibiotic duration by about 1 day, but questions about safety remain.
CDC Allows Novavax Monovalent COVID-19 Boosters for Adults Ages 18 and Older
Description
Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.